Tarsus Medical Education (TME)


Tarsus Medical Education (TME) is an exemplary medical education company that develops innovative and uniquely customized medical education activities for healthcare professionals. Recognized for our rich relationships with key opinion leaders and scientific expertise, TME activities are dedicated to providing quality education with the ultimate goal of improving patient outcomes.

TME has experience in developing, implementing, and analyzing CME/CE activities across a wide variety of formats, including live events; print newsletters, monographs, and peer-reviewed journal supplements; electronic media; and web-based activities, including on-demand webinars, podcasts, mobile applications, and interdisciplinary web conferences, as well as website design, development, and maintenance.

TME is dedicated to providing effective education based on the needs of the medical community. Working with key thought leaders in a variety of therapeutic areas enables us to develop dynamic, innovative medical education activities designed to improve patient care strategies and patient outcomes by modifying clinician behavior through the presentation of evidence-based, compelling, and pertinent information.

Recent courses

Title Credit
The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 ANCC
    • 1.00 Participation
A New Wave of Topical Therapies for Atopic Dermatitis: Comparing Treatment Approaches
    • 1.00 AANP
    • 1.00 AAPA Category I CME
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 ANCC
    • 1.00 Participation
The Burden of Resistant Hypertension in Women: Novel and Emerging Approaches to Improve Outcomes
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 ANCC
    • 0.50 Participation
Ace the Case Challenge Series: The Intersection of MASH and Cardiometabolic Risk
    • 0.50 CDE
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 ANCC
    • 0.50 Participation
Ace the Case Challenge Series: Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit
    • 0.75 ANCC
    • 0.75 Participation
Understanding the Role of Lp(a) as a CV Risk Marker to Therapeutic Target in the Prevention of ASCVD
    • 1.50 CDE
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit
    • 1.50 ANCC
    • 1.50 Participation
Advances in Non-Steroidal Topicals: PDE-4 Inhibitors for Seborrheic Dermatitis and Beyond
    • 0.75 AMA PRA Category 1 Credit
    • 0.75 ANCC
    • 0.75 Participation
Psoriasis in Skin of Color Unplugged: Addressing the Barriers to Patient Care and Relief
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 ANCC
    • 1.00 Participation
Expanding the Therapeutic “AHR”senal for Pediatric Atopic Dermatitis
    • 1.00 AAPA Category I CME
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 ANCC
    • 1.00 Participation
Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift
    • 1.50 CDE
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit
    • 1.50 ANCC
    • 1.50 Participation

Therapeutic Area Expertise

  • Aesthetics
  • Anti-Aging Medicine 
  • Cardiology 
  • Cardiometabolic Health
  • Dermatology 
  • Diabetes
  • Endocrinology 
  • Heart Failure
  • Hemophilia 
  • Immunology 
  • Integrative Health
  • Lifestyle Medicine
  • Lipids
  • NASH/NAFLD
  • Nephrology 
  • Neurology
  • Nutrition
  • Obesity 
  • Oncology 
  • Pain
  • Pediatric Dermatology 
  • Pediatrics
  • Pulmonology